XML 50 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings (Loss) Per Share
9 Months Ended 12 Months Ended
Sep. 30, 2020
Dec. 31, 2019
Earnings Per Share [Abstract]    
Earnings (Loss) Per Share
Note 11. Earnings (Loss) Per Share
Founders’ Preferred Stock, Series A Convertible Preferred Stock, Series X Convertible Preferred Stock, and unvested Restricted Stock Awards (“RSAs”) are participating securities in periods of income, as the Founders’ Preferred Stock, Series A Convertible Preferred Stock, Series X Convertible Preferred Stock, and unvested RSAs
participate in undistributed earnings on an
as-if-converted
or
as-vested
basis. However, the Founders’ Preferred Stock, Convertible Preferred Stock, and unvested RSAs do not share in losses. The Company computes earnings per share of common stock using the
two-class
method required for participating securities and does not apply the
two-class
method in periods of net loss. Basic and diluted earnings per share was the same for each period presented as the inclusion of all potential common stock outstanding would have been anti-dilutive. The following table sets forth the computation of basic and diluted loss for the nine months (in thousands, except for share and per share amounts):
 
    
Nine Months ended
September 30,
 
    
2020
    
2019
 
               
Numerator:
     
Net loss
   $ (72,227    $ (76,774
Deemed dividend attributable to BCF
     (6,247      (5,282
  
 
 
    
 
 
 
Net loss attributable to common shareholders
   $ (78,474    $ (82,056
  
 
 
    
 
 
 
     
Denominator:
     
Weighted average Common shares outstanding- Basic
     9,510,996        8,676,669  
  
 
 
    
 
 
 
Dilutive effect of potential common shares
     —          —    
  
 
 
    
 
 
 
Weighted average Common shares outstanding- Diluted
     9,510,996        8,676,669  
  
 
 
    
 
 
 
Net loss per shares attributable to Common shareholders-Basic and Diluted
   $ (8.25    $ (9.46
  
 
 
    
 
 
 
The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock for the periods presented because including them would have been antidilutive:
 
    
Nine Months ended
September 30,
 
    
2020
    
2019
 
               
Warrants
     444,023        71,281  
Stock options
     1,199,974        148,988  
Restricted Stock
     161,549        542,610  
Series A Convertible Preferred Stock
     6,956,100        6,956,100  
Series X Convertible Preferred Stock
     1,251,971        —    
Founders Preferred Stock
     1,922,600        1,922,600  
  
 
 
    
 
 
 
Total
     11,936,217        9,641,579  
  
 
 
    
 
 
 
Note 14. Earnings (Loss) Per Share
Founders Preferred Stock, Series A Convertible Preferred Stock, and unvested Restricted Stock Awards (“RSA”) are participating securities in periods of income, as the Founders Preferred Stock, Series A Convertible Preferred Stock, and unvested RSAs participate in undistributed earnings on an
as-if-converted
or
as-vested
basis. However, the Founders Preferred Stock, Series A Convertible Preferred Stock, and unvested RSAs do not share in losses. The Company computes earnings per share of Common Stock using the
two-class
method required for participating securities and does not apply the
two-class
method in periods of net loss. Basic and diluted earnings per share was the same for each year presented as the inclusion of all potential Common Stock outstanding would have been anti-dilutive. The following table sets forth the computation of basic and diluted loss (in thousands, except for share and per share amounts):
 
    
As of December 31,
 
    
2019
    
2018
 
Numerator:
     
Net loss
   $ (94,718    $ (79,550
Deemed dividend attributable to BCF accretion
     (5,282      —    
  
 
 
    
 
 
 
Net loss attributable to common shareholders
     (100,000      (79,550
  
 
 
    
 
 
 
Denominator:
     
Weighted average Common shares outstanding- Basic
     8,718,104        6,631,873  
Dilutive effect of potential common shares
     —          —    
  
 
 
    
 
 
 
Weighted average Common shares outstanding- Diluted
     8,718,104        6,631,873  
  
 
 
    
 
 
 
Net loss per shares attributable to Common shareholders- Basic and Diluted
   $ (11.47    $ (12.00
  
 
 
    
 
 
 
The following table presents the potential shares of Common Stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
 
    
As of December 31,
 
    
2019
    
2018
 
Warrants
     71,281        71,281  
Stock Options
     365,938        —    
Restricted Stock
     460,257        1,693,491  
Series A Convertible Preferred Stock
     6,956,100        —    
Founders Preferred Stock
     1,922,600        1,922,600  
SAFE
     —          4,488,738  
  
 
 
    
 
 
 
Total
     9,776,176        8,176,110  
  
 
 
    
 
 
 
The SAFEs are not included in basic EPS until settlement. For purposes of diluted EPS, the Company applies the if-converted method. However, because the SAFEs’ non-market-based exercise contingencies were not met prior to settlement and the adjustment to the numerator for mark-to-market losses in the period that the contingencies were met caused the instruments to be antidilutive, the SAFEs were not included in diluted EPS. Please refer to Note 7 for the key terms of the SAFEs.